Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
357
-
Total 13F shares, excl. options
-
177M
-
Shares change
-
+122M
-
Total reported value, excl. options
-
$3.61B
-
Value change
-
+$2.48B
-
Put/Call ratio
-
1.04
-
Number of buys
-
324
-
Number of sells
-
-21
-
Price
-
$20.37
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2019
398 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2019.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 357 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177M shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (26.1M shares), PAULSON & CO. INC. (13.2M shares), BAUPOST GROUP LLC/MA (10.7M shares), Adelphi Capital LLP (9.27M shares), FMR LLC (7.56M shares), VANGUARD GROUP INC (6.7M shares), TIAA CREF INVESTMENT MANAGEMENT LLC (6.56M shares), Sachem Head Capital Management LP (5.96M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.96M shares), and MACQUARIE GROUP LTD (4.78M shares).
This table shows the top 357 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.